Semanteon Capital Management, LP Amicus Therapeutics, Inc. Transaction History

Semanteon Capital Management, LP

  • $66.3 Billion
  • Q2 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
SELL
$8.16 - $9.85 $1.04 Million - $1.26 Million
-127,482 Reduced 85.47%
21,674 $177 Million
Q4 2024

Feb 11, 2025
BUY
$9.36 - $12.01 $405,175 - $519,888
43,288 Added 40.89%
149,156 $1.41 Billion
Q3 2024

Oct 24, 2024
BUY
$9.55 - $12.09 $1.01 Million - $1.28 Million
105,868 New
105,868 $1.13 Billion

Others Institutions Holding FOLD

# of Institutions
309
Shares Held
326M
Call Options Held
378K
Put Options Held
575K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $1.96B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Semanteon Capital Management, LP Portfolio

Follow Semanteon Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Semanteon Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Semanteon Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email